Project Grant HT9425261E097
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $1.8M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.18 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, through August 31, 2028. This award supports research focused on overcoming immunotherapy resistance in acral melanoma, a specialized oncology research initiative aligned with the Defense Health Agency's mission to advance biomedical solutions for Service...
- Federal Grant Award Summary The University of Pittsburgh received a $1.144M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This research initiative addresses overcoming immunotherapy resistance in acral melanoma, a critical oncology research priority within the DHA's comprehensive portfolio of biomedical research initiatives. The grant supports hypothesis-driven...
- Federal Grant Award Summary The University of Pittsburgh received a $1,008,763 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate profilin-1's (Pfn1) role in chromophobe renal cell carcinoma (ChRCC) mitochondria and tumorigenesis. The award, effective September 1, 2025, through August 31, 2029, supports hypothesis-driven biomedical research designed to advance innovative medical solutions for critical health...
- Federal Grant Award Summary The University of Pittsburgh received a $986,228 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025 through May 31, 2029. The award supports research to identify and characterize pathways of progression from acute pancreatitis to recurrent acute pancreatitis and chronic pancreatitis. This research is designed to generate scientific knowledge and insights that advance...
- Federal Grant Award Summary The University of Pittsburgh received a $300,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025, through September 30, 2027. The award supports research aimed at uncovering the nuclear antigens recognized by autoreactive T cells in systemic lupus erythematosus (SLE). This hypothesis-driven research initiative contributes to the DHA's broader mission of...
- Federal Project Grant Award Summary The University of Pittsburgh received a $2.45M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2025 through September 29, 2028. The award supports research on biomechanical and physiological resilience and recovery in load carriage, with work performed at the university's Pittsburgh, Pennsylvania facility. This research initiative aligns with the Defense Health...
- Federal Grant Award Summary The University of Pittsburgh received a $673,197 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 15, 2025, through August 14, 2027. The award supports research focused on harmonization of severe traumatic brain injury (TBI) multiomic analyses within the BioBoost and BioHobit research initiatives. This project delivers biomedical research services designed to advance...
- This federal Project Grant award of $4,902,315.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "UNDERSTANDING THE EFFECTS OF INTRACAVITARY CONDITIONING IN BREAST CANCER METASTATIC TO THE PLEURA OR THE PERITONEUM" at the University of Pittsburgh. The project aims to conduct advanced biomedical research focused on developing innovative medical solutions to address critical health challenges relevant to...
- Federal Grant Award Summary The University of Pittsburgh received a $2.67 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded August 15, 2025, with a completion date of August 14, 2029. The grant funds "A Collaborative Multiomic Approach to Pediatric Scleroderma (CMAPS) to Molecularly Characterize and Stratify Patients," a research initiative designed to advance the understanding and treatment of...
- Federal Grant Award Summary The University of Pittsburgh received a $434,722 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with an ultimate completion date of August 14, 2029. The grant supports "A Collaborative Multiomic Approach to Pediatric Scleroderma" (CMAPS), a research initiative designed to molecularly characterize and stratify pediatric scleroderma patients. This four-year...